Speciation of arsenic in urine following intravenous administration of arsthinol in mice

Recent investigations have shown that arsthinol, a trivalent organoarsenic compound (dithiarsolane), has been active in vitro on leukemia cell lines and offers a better therapeutic index than arsenic trioxide, as estimated by the ratio LD 50 /IC 50 . To complete our understanding of its urinary excr...

Full description

Saved in:
Bibliographic Details
Published in:European journal of drug metabolism and pharmacokinetics Vol. 35; no. 1-2; pp. 59 - 65
Main Authors: Ajana, Imane, Astier, Alain, Gibaud, Stéphane
Format: Journal Article
Language:English
Published: Paris Springer-Verlag 01-09-2010
Médecine & hygiène
Springer
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Recent investigations have shown that arsthinol, a trivalent organoarsenic compound (dithiarsolane), has been active in vitro on leukemia cell lines and offers a better therapeutic index than arsenic trioxide, as estimated by the ratio LD 50 /IC 50 . To complete our understanding of its urinary excretion, a sensitive method using liquid chromatography coupled with mass spectrometry (LC-MS) was used. Mice were injected intravenously with a single dose of arsthinol at 0.2 mmol/kg of body weight. The amount of total arsenic in tissues and body fluids was determined by a colorimetric method and urine metabolites were analyzed on a C18 Acclaim PepMap 100 Å column by LC-MS. Our results showed that only three arsenic species (acetarsol, acetarsol oxide and arsthinol) were detected in the first 24-h urine. Overall, this study confirms that the hydrolysis of dithiarsolanes to arsenoxides (i.e. acetarsol oxide) can be followed by an oxidation in arsonic acids (i.e. acetarsol). All these compounds are excreted in the urine.
ISSN:0378-7966
2107-0180
DOI:10.1007/s13318-010-0009-6